Table 4.

Demographic, BP, and echocardiographic data for residual renal artery patency groups and for unilateral and bilateral renal artery disease groups

Baseline (n = 79)Mild ARVDModerate ARVDSevereARVDPUnilateral ARVDBilateral ARVDP
n26 (32.9%)45 (57%)8 (10.1%)51 (64.6%)28 (35.4%)
Age (yr)71.3 ± 5.070.4 ± 8.670.3 ± 8.6NS70.1 ± 8.171.9 ± 6.3NS
eGFR (ml/min)36.4 ± 20.635.9 ± 18.437.7 ± 20.9NS37.9 ± 19.233.3 ± 19.1NS
Proteinuria (g/24 h)0.4 ± 0.41.5 ± 0.30.5 ± 0.9NS0.3 ± 0.40.4 ± 0.6NS
24-h systolic BP (mmHg)141.0 ± 21.6138.5 ± 19.1139.6 ± 9.9NS141.5 ± 18.6135.7 ± 19.6NS
24-h diastolic BP (mmHg)72.4 ± 14.172.1 ± 12.476.4 ± 12.0NS74.8 ± 13.168.9 ± 11.7NS
24-h MAP (mmHg)96.8 ± 15.295.6 ± 13.599.1 ± 9.1NS98.8 ± 13.792.1 ± 12.6<0.05
LVH (%)76.980.075.0NS74.585.7NS
LVMI (g/m2)174.1 ± 49.7181.5 ± 83.2179.0 ± 67.3NS167.1 ± 58.8200.2 ± 87.4<0.05
LVEF (%)49.2 ± 13.455.3 ± 9.950.93 ± 14.4NS53.5 ± 11.851.5 ± 11.8NS
LVEDD (cm)5.3 ± 0.65.4 ± 1.15.4 ± 0.8NS5.2 ± 0.85.8 ± 1.1<0.01
LVEDV (ml)150.9 ± 61.9147.6 ± 65.9139.0 ± 36.1NS141.4 ± 50.1159.6 ± 78.3NS
Cholesterol (mmol/L)4.5 ± 1.04.8 ± 1.15.0 ± 1.5NS4.7 ± 1.14.7 ± 1.2NS
Calcium-phosphate product (mmol/L)2.6 ± 0.72.8 ± 0.82.5 ± 0.6NS2.7 ± 0.62.8 ± 1.0NS